BM 13.907

is known to increase the translocation of glucose-carriers and lowers blood glucose in animal models of non-insulin dependent diabetes mellitus

Also Known As:

5-(4-chlorophenyl)-2-(4-methylphenylsulfonyl)-4-pentynoic acid

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)